Kala Pharma: 4Q Earnings Snapshot

February 12, 2020 GMT

WALTHAM, Mass. (AP) _ Kala Pharmaceuticals Inc. (KALA) on Wednesday reported a loss of $22 million in its fourth quarter.

The Waltham, Massachusetts-based company said it had a loss of 63 cents per share.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 60 cents per share.

The biopharmaceutical company posted revenue of $1.2 million in the period, also missing Street forecasts. Five analysts surveyed by Zacks expected $2.9 million.

For the year, the company reported that its loss widened to $94.3 million, or $2.76 per share. Revenue was reported as $6.1 million.

Kala Pharma shares have increased 73% since the beginning of the year. The stock has decreased nearly 4% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KALA at https://www.zacks.com/ap/KALA